Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx

FASEB Journal

Volumn 27, Issue 6, 2013, Pages 2496-2503

  Jin, Lei ^a,b   Sturgis, Erich M ^a,b   Cao, Xiaolin ^a   Song, Xicheng ^a,c   Salahuddin, Taufiq ^a   Wei, Qingyi ^a   Li, Guojun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Biomarkers; HPV; IL 10 variants; Oropharyngeal cancer; Smoking; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 10; VIRUS DNA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF OROPHARYNX;

BIOMARKERS; HPV; IL-10 VARIANTS; OROPHARYNGEAL CANCER; SMOKING; SURVIVAL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SURVIVORS;

HUMAN PAPILLOMAVIRUS;

EID: 84878763609     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-226803     Document Type: Article

References (37)

1. Sturgis, E. M., and Cinciripini, P. M. (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110, 1429-14355
2. Siegel, R., Naishadham, D., and Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-299
3. Vineis, P., Alavanja, M., Buffler, P., Fontham, E., Franceschi, S., Gao, Y. T., Gupta, P. C., Hackshaw, A., Matos, E., Samet, J., Sitas, F., Smith, J., Stayner, L., Straif, K., Thun, M. J., Wichmann, H. E., Wu, A. H., Zaridze, D., Peto, R., and Doll, R. (2004) Tobacco and cancer: recent epidemiological evidence. J. Natl. Cancer Inst. 96, 99-1066
4. Dahlstrom, K. R., Adler-Storthz, K., Etzel, C. J., Liu, Z., Dillon, L., El-Naggar, A. K., Spitz, M. R., Schiller, J. T., Wei, Q., and Sturgis, E. M. (2003) Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in neversmokers: a matched pair analysis. Clin. Cancer Res. 9, 2620-26266
5. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., and Sidransky, D. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709-7200
6. Marur, S., D'Souza, G., Westra, W. H., and Forastiere, A. A. (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 11, 781-7899
7. Hammarstedt, L., Lindquist, D., Dahlstrand, H., Romanitan, M., Dahlgren, L. O., Joneberg, J., Creson, N., Lindholm, J., Ye, W., Dalianis, T., and Munck-Wikland, E. (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int. J. Cancer 119, 2620-26233
8. Sturgis, E. M., and Wei, Q. (2002) Genetic susceptibility- molecular epidemiology of head and neck cancer. Curr. Opin. Oncol. 14, 310-3177
9. Ritchie, J. M., Smith, E. M., Summersgill, K. F., Hoffman, H. T., Wang, D., Klussmann, J. P., Turek, L. P., and Haugen, T. H. (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int. J. Cancer 104, 336-3444
10. Mellin, H., Friesland, S., Lewensohn, R., Dalianis, T., and Munck-Wikland, E. (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int. J. Cancer 89, 300-3044
11. Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., and Mosmann, T. R. (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248, 1230-12344
12. Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M., Sinnott, P. J., and Hutchinson, I. V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24, 1-88
13. Westendorp, R. G., Langermans, J. A., Huizinga, T. W., Elouali, A. H., Verweij, C. L., Boomsma, D. I., and Vandenbroucke, J. P. (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349, 170-1733
14. Farzaneh, F., Roberts, S., Mandal, D., Ollier, B., Winters, U., Kitchener, H. C., and Brabin, L. (2006) The IL-10-1082G polymorphism is associated with clearance of HPV infection. BJOG 113, 961-9644
15. Bolpetti, A., Silva, J. S., Villa, L. L., and Lepique, A. P. (2010) Interleukin-10 production by tumor infiltrating macrophages plays a role in human papillomavirus 16 tumor growth. BMC Immunol. 11, 277
16. Guan, X., Sturgis, E. M., Lei, D., Liu, Z., Dahlstrom, K. R., Wei, Q., and Li, G. (2010) Association of TGF-β1 genetic variants with HPV16-positive oropharyngeal cancer. Clin. Cancer Res. 16, 1416-14222
17. Park, J. S., Kim, E. J., Lee, J. Y., Sin, H. S., Namkoong, S. E., and Um, S. J. (2001) Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int. J. Cancer 91, 822-8277
18. Ji, X., Sturgis, E. M., Zhao, C., Etzel, C. J., Wei, Q., and Li, G. (2009) Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer 115, 1660-16688
19. Miller, D. L., Puricelli, M. D., and Stack, M. S. (2012) Virology and molecular pathogenesis of HPV (human papillomavirus)- associated oropharyngeal squamous cell carcinoma. Biochem. J. 443, 339-3533
20. Miller, C. S., and Johnstone, B. M. (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a metaanalysis, 1982-1997. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91, 622-6355
21. De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-12200
22. Kundu, N., Beaty, T. L., Jackson, M. J., and Fulton, A. M. (1996) Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl. Cancer Inst. 88, 536-5411
23. + T lymphocyte migration. J. Immunol. 151, 4545-45511
24. Te Velde, A. A., de Waal Malefijt, R., Huijbens, R. J., de Vries, J. E., and Figdor, C. G. (1992) IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFNgamma, IL-4, and IL-10. J. Immunol. 149, 4048-40522
25. Rousset, F., Garcia, E., Defrance, T., Peronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., and Banchereau, J. (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 89, 1890-18933
26. Huang, S., Ullrich, S. E., and Bar-Eli, M. (1999) Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J. Interferon Cytokine Res. 19, 697-7033
27. Fortis, C., Foppoli, M., Gianotti, L., Galli, L., Citterio, G., Consogno, G., Gentilini, O., and Braga, M. (1996) Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett. 104, 1-55
28. Lech-Maranda, E., Baseggio, L., Bienvenu, J., Charlot, C., Berger, F., Rigal, D., Warzocha, K., Coiffier, B., and Salles, G. (2004) Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103, 3529-35344
29. Seifart, C., Plagens, A., Dempfle, A., Clostermann, U., Vogelmeier, C., von Wichert, P., and Seifart, U. (2005) TNF-alpha, TNF-α, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis. Markers 21, 157-1655
30. Yao, J. G., Gao, L. B., Liu, Y. G., Li, J., and Pang, G. F. (2008) Genetic variation in interleukin-10 gene and risk of oral cancer. Clin. Chim. Acta. 388, 84-888
31. Michaud, D. S., Daugherty, S. E., Berndt, S. I., Platz, E. A., Yeager, M., Crawford, E. D., Hsing, A., Huang, W. Y., and Hayes, R. B. (2006) Genetic polymorphisms of interleukin-1β (IL-1β), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 66, 4525-45300
32. Zoodsma, M., Nolte, I. M., Schipper, M., Oosterom, E., van der Steege, G., de Vries, E. G., Te Meerman, G. J., and van der Zee, A. G. (2005) Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int. J. Gynecol. Cancer 15, Suppl. 3, 282-2900
33. Jeong, S. W., Tae, K., Lee, S. H., Kim, K. R., Park, C. W., Park, B. L., and Shin, H. D. (2010) Cox-2 and IL-10 polymorphisms and association with squamous cell carcinoma of the head and neck in a Korean sample J. Korean Med. Sci. 25, 1024-10288
34. Ivansson, E. L., Gustavsson, I. M., Magnusson, J. J., Steiner, L. L., Magnusson, P. K., Erlich, H. A., and Gyllensten, U. B. (2007) Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int. J. Cancer 121, 2451-24577
35. Shrestha, S., Wang, C., Aissani, B., Wilson, C. M., Tang, J., and Kaslow, R. A. (2007) Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents. Cancer Epidemiol. Biomarkers Prev. 16, 1626-16322
36. Gerger, A., Renner, W., Langsenlehner, T., Hofmann, G., Knechtel, G., Szkandera, J., Samonigg, H., Krippl, P., and Langsenlehner, U. (2010) Association of interleukin-10 gene variation with breast cancer prognosis. Breast Cancer Res. Treat. 119, 701-7055
37. Vuoristo, M. S. (2007) The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma. Cancer Genet. Cytogenet. 176, 54-577